Evidence map›Paper›PMID 35320882›Full record

Observational studyJournal of gynecologic oncology2022

Significance of histology and nodal status on the survival of women with early-stage cervical cancer: validation of the 2018 FIGO cervical cancer staging system.

Hiroko Machida, Koji Matsuo, Yoichi Kobayashi, Mai Momomura, Fumiaki Takahashi, Tsutomu Tabata, Eiji Kondo, Wataru Yamagami, Yasuhiko Ebina, Masanori Kaneuchi and 2 more

Open access · diamondAbstract readObservational Study
In one paragraph

Observational study in Journal of gynecologic oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 2 countries.

Hiroko MachidaDepartment of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan.ORCID 0000-0003-2252-3577
Koji MatsuoDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.ORCID 0000-0002-6232-8701
Yoichi KobayashiDepartment of Obstetrics and Gynecology, Kyorin University, Tokyo, Japan.ORCID 0000-0002-8474-0625
Mai MomomuraDepartment of Obstetrics and Gynecology, Kyorin University, Tokyo, Japan.ORCID 0000-0002-4749-8403
Fumiaki TakahashiDivision of Medical Engineering, Department of Information Science, Iwate Medical University, Morioka, Japan.ORCID 0000-0001-9201-1089
Tsutomu TabataDepartment of Obstetrics and Gynecology, Tokyo Women's Medical University, Tokyo, Japan.ORCID 0000-0003-0243-8180
Eiji KondoDepartment of Obstetrics and Gynecology, Mie University, Mie, Japan.ORCID 0000-0001-9773-2520
Wataru YamagamiDepartment of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0003-3925-6057
Yasuhiko EbinaFaculty of Health Sciences, Hokkaido University, Sapporo, Japan.ORCID 0000-0002-4119-7546
Masanori KaneuchiDepartment of Obstetrics and Gynecology, Otaru General Hospital, Hokkaido, Japan.ORCID 0000-0002-2479-1164
Satoru NagaseDepartment of Obstetrics and Gynecology, Yamagata University, Yamagata, Japan.ORCID 0000-0001-5212-1128
Mikio MikamiDepartment of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa, Japan. mmikami@is.icc.u-tokai.ac.jp.ORCID 0000-0002-7496-3518
Kyorin University · JPTokai University · JPIwate Medical University · JPKeio University · JPMie University · JPOtaru Municipal Hospital · JPSapporo University · JPTokyo Women's Medical University · JPUniversity of Southern California · USYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the efficacy of the FIGO 2018 classification system for nodal-specific classifications for early-stage cervical cancer; specifically, to examine the impact of nodal metastasis on survival and the effect of postoperative treatments, according to histological subtypes.

methodsThis society-based retrospective observational study in Japan examined 16,539 women with the 2009 FIGO stage IB1 cervical cancer who underwent primary surgical treatment from 2004 to 2015. Associations of cause-specific survival (CSS) with nodal metastasis and postoperative adjuvant therapy were examined according to histology type (squamous cell carcinoma [SCC], n=10,315; and non-SCC, n=6,224).

resultsThe nodal metastasis rate for SCC was higher than that for non-SCC (10.7% vs. 8.3%, p<0.001). In multivariable analysis, the impact of nodal metastasis on CSS was greater for non-SCC tumors (adjusted-hazard ratio [HR], 3.11; 95% confidence interval [CI], 2.40-4.02) than for SCC tumors (adjusted-HR, 2.20; 95% CI, 1.70-2.84; p<0.001). Propensity score matching analysis showed significantly lower CSS rates for women with pelvic nodal metastasis from non-SCC tumors than from SCC tumors (5-year CSS rate, 75.4% vs. 90.3%, p<0.001). The CSS rates for women with nodal metastasis in SCC histology were similar between the postoperative concurrent chemoradiotherapy/radiotherapy and chemotherapy groups (89.2% vs. 86.1%, p=0.42), whereas those in non-SCC histology who received postoperative chemotherapy improved the CSS (74.1% vs. 67.7%, p=0.043).

conclusionThe node-specific staging system in the 2018 FIGO cervical cancer classification is applicable to both non-SCC tumors and SCC tumors; however, the prognostic significance of nodal metastases and efficacy of postoperative therapies vary according to histology.

Indexed as

Carcinoma, Squamous CellUterine Cervical NeoplasmsFemaleHumansLymph NodesNeoplasm StagingPrognosisRetrospective StudiesHistological Type of NeoplasmLymph Node MetastasisNeoplasm StagingSurvivalUterine Cervical Neoplasms

Identifiers

PMID35320882
PMCPMC9024192
OpenAlexW4210834736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.